Drug Shortage Report for TEVA-ACYCLOVIR

Last updated on 2021-01-14 History
Report ID 122712
Drug Identification Number 02285967
Brand name TEVA-ACYCLOVIR
Common or Proper name TEVA-ACYCLOVIR 400MG TABLETS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR
Strength(s) 400MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-20
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-01-14
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-01-14 French Compare
v8 2021-01-14 English Compare
v7 2021-01-07 French Compare
v6 2021-01-07 English Compare
v5 2020-10-01 French Compare
v4 2020-10-01 English Compare
v3 2020-08-21 English Compare
v2 2020-08-20 French Compare
v1 2020-08-20 English Compare